The licence applies to adults with a BMI of 27 or above who have established cardiovascular disease
Some individuals may achieve their desired results and maintain their weight loss on a lower dose, while others may require the maximum dose
If you find that appetite suppression alone does not change your eating behaviors, that is equally valuable information that can guide future treatment decisions
However, low blood sugar can occur while using Ozempic
When Switching Makes Clinical Sense Patients switch between GLP-1 receptor agonists for several reasons: intolerable gastrointestinal side effects, insufficient A1C response, insurance formulary changes, or a strong preference for oral versus injectable dosing
The additives used in compounded GLP-1 therapy are well studied, widely used, and considered safe at therapeutic doses